Clinical trial
Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal…
NCT00387010 · Cephalon, Industry · Terminated
Key facts
| NCT number | NCT00387010 |
|---|---|
| Title | Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain |
| Official title | A 4-week Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain |
| Lead sponsor | Cephalon, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Chronic Pain, Breakthrough Pain |
| Intervention type | Drug |
| Interventions | Fentanyl Buccal Tablets |
| Enrollment | 218 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Oct 12, 2006 |
| Last update posted | Oct 22, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: